FDA Approves MiniTC for Fat Tissue Processing and Other Applications

Jointechlabs – a provider of point-of-care regenerative medicine therapies – announces that the US Food and Drug Administration (FDA) has cleared the company's MiniTC for point-of-care fat tissue processing designed to obtain microfat (or fat grafts), for multiple indications.